NorthWest Biotherapeutics Inc (NWBO)

[j e d]

Looking just at the MGMT methylated patients, and varying placebo mOS and varying the DCVax:Placebo ratio (as we don't know it within just the methylated group, although since the trial is randomized it should be close to the overall ratio of 2.34:1), here is what I found to be the mOS of MGMT methylated patients who were administered DCVax:


and a quick test to see that the ratio range within the methylated group (n=131) seems reasonable:


The interim results look very encouraging IMO.